United States · FDA National Drug Code directory

Lisinopril

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68180-513_6723a96d-02f8-40c2-95ec-89a7053a7117
Product NDC: 68180-513
Form: TABLET
Composition / generic term: Lisinopril
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20060113
Source listing expiry: 20261231

Source-listed ingredients

LISINOPRIL — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (68180-513-01) · 68180-513-01
1000 TABLET in 1 BOTTLE (68180-513-03) · 68180-513-03
5000 TABLET in 1 POUCH (68180-513-30) · 68180-513-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →